Both AEF and Platinum were reluctant sellers but the COVID climate changed everything for these Funds...My guess is that Anp will sell the VOUCHER and go it alone re DMD in Europe and America...
I think everything is on the back burner including Acromegaly....
But whilst the Trials are conducted in Europe and the US.. Other indications inc Acromegaly will be partnered for more $$$$
The Rome Cohort, page-68
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.002(2.47%) |
Mkt cap ! $81.90M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.1¢ | 7.8¢ | $1.034M | 12.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 349999 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 305419 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |